002317 众生药业
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.7646.917-7.2346.5348.973
总资产报酬率 ROA (%)2.2075.162-4.9814.3046.032
投入资产回报率 ROIC (%)2.5015.840-5.5594.7986.656

边际利润分析
销售毛利率 (%)56.32556.11956.03458.59664.857
营业利润率 (%)11.92611.824-11.34611.44313.985
息税前利润/营业总收入 (%)12.15411.548-13.25511.50915.901
净利润/营业总收入 (%)10.67010.572-15.1569.57311.784

收益指标分析
经营活动净收益/利润总额(%)90.467100.137-71.135111.06888.538
价值变动净收益/利润总额(%)-12.913-0.982-1.980-14.7027.290
营业外收支净额/利润总额(%)3.467-0.57816.652-5.314-1.618

偿债能力分析
流动比率 (X)4.8604.2372.8773.9012.918
速动比率 (X)4.2393.7292.5103.3882.484
资产负债率 (%)17.64119.09927.79129.92733.917
带息债务/全部投入资本 (%)3.8093.65414.22610.78117.491
股东权益/带息债务 (%)2,374.2402,476.886554.749696.408409.311
股东权益/负债合计 (%)456.933414.223253.650225.383189.029
利息保障倍数 (X)-60.493-55.285-37.05117.9007.436

营运能力分析
应收账款周转天数 (天)95.45478.91073.95367.71866.894
存货周转天数 (天)154.729131.182159.599166.773178.616